Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline

Details for Australian Patent Application No. 2003220016 (hide)

Owner Somerset Pharmaceuticals, Inc.

Inventors Blume, Cheryl D; Disanto, Anthony R

Agent Davies Collison Cave

Pub. Number AU-B-2003220016

PCT Number PCT/US03/06690

PCT Pub. Number WO2003/075906

Priority 60/361,609 04.03.02 US

Filing date 4 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 1 March 2007

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/361,609 04.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003220016

1 March 2007 Application Accepted

  Published as AU-B-2003220016

28 June 2007 Standard Patent Sealed

1 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220017-SYSTEM AND METHOD FOR DYNAMICALLY ESTABLISHING OPTIMUM AUDIO QUALITY IN AN AUDIO CONFERENCE

2003220015-IN SITU MICROBIAL STABILIZATION OF METALS USING PHOSPHATE AMENDED BIOVENTING/BIOSPARGING